C C HARLAND CONSULTANT DERMATOLOGIST LIMITED

Executive Summary

C C Harland Consultant Dermatologist Limited is a small, owner-operated specialist medical practice in a strong liquidity position with growing net assets and no overdue filings, indicating low immediate financial or regulatory risk. Operationally, the company’s sustainability depends heavily on its sole director, and further review of profitability and director transactions is recommended to ensure long-term stability. Overall, the company presents as a low-risk investment opportunity within its niche.

C C HARLAND CONSULTANT DERMATOLOGIST LIMITED - Analysis Report

Company Number: 13887279

Analysis Date: 2025-07-20 16:49 UTC

1. Risk Rating: LOW
   The company demonstrates positive net current assets, growing net assets, and no overdue filings, indicating sound financial health and good compliance. The absence of employees and reliance on a single director-owner are typical of small specialist consultancies but do not currently raise operational or regulatory concerns.

2. Key Concerns:

• Single Director and PSC: Dr. Christopher Charles Harland holds 100% control and is the sole director, which concentrates operational and governance risk in one individual.
• Small Scale and No Employees: The company operates without employees, which may limit scalability and operational resilience.
• Director Advances: There is a minor outstanding director loan balance (£146) which is small but should be monitored for any unusual director-related transactions.

3. Positive Indicators:

• Strong Liquidity: Cash of £60,110 exceeds current liabilities of £36,233, reflecting good short-term liquidity.
• Growing Net Assets: Net assets increased from £34,912 (2023) to £52,159 (2024), showing positive retained earnings.
• Timely Compliance: All statutory filings (accounts and confirmation statements) are up to date with no overdue notices.
• Industry Focus: Specialist medical practice activity (SIC 86220) typically indicates a niche market with potentially stable demand.

4. Due Diligence Notes:

• Review the income statement and cash flow details (not provided) to assess profitability and operational cash flow sustainability.
• Clarify nature and terms of director advances to ensure no hidden financial risks or related party concerns.
• Assess dependency risk on the sole director for business continuity and consider governance safeguards.
• Confirm absence of contingent liabilities or off-balance sheet risks not disclosed in abridged accounts.
• Verify the scope of services and client base to understand revenue concentration and market risk.